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Dr Chris Kwolek (Boston, Mass). I would like to congratu-
late Dr Greenstein and his coauthors on a very nice presentation
and thank them for providing me with a copy of their manuscript
well in advance of this meeting. The authors described the results
of a contemporary series, although retrospective, of carotid endar-
terectomy and a large cohort of patients performed by 482 sur-
geons in over 167 hospitals within the state of New York with a
very reasonable death and stroke rate for symptomatic and asymp-
tomatic patients. In this era of increased concern about the role of
carotid endarterectomy versus carotid angioplasty and stenting,
and the management of the patients with carotid stenosis, I think
this paper will be increasingly important. However, I am a little bit
intrigued by the methodology and I will get to my question in a
moment.
We have reported a 10% incidence of minor complications,
including an incidence of 5.5% of cranial nerve injuries, 5% incidence
of hematoma, one-third ofwhich required surgical re-exploration. So,
approximately 1.5% to 2% required a surgical re-exploration, and the
author very interestingly notes that the existence of one of these
complications also greatly increases the risk of concomitant stroke and
potentially death, at least for the cranial nerve injuries both stroke
alone and for hematoma, stroke, and death in a threefold to fourfold
manner. You alluded to it in your presentation, but one wonders,
what is the etiology of this relationship? It is that these are complex
patients? I think very appropriately, patients who have combined
carotid CABGs or redo procedures were factored out of the evalua-
tion initially, but it begs the question. Is this merely a marker perhaps
for operator experience?
So my first question is, do you have any data about the results
of individual surgeons since you allude to it in your final slide and
how did that play out with respect to results? And then the second
question, we also know there has been some interest on a national
level both by the American College of Surgeons and the NSQIP
[National Surgical Quality Improvement Program] as to hospital
dependent rates as well as surgeon independent rates. I would like
you to comment on the higher incidence of significant complica-
tions in a very contemporary series albeit it across the large state-
wide registry. When we compare your results to such retrospective
reviews that Bruce Perler has presented from the state of Maryland
and the large retrospective reviews from similar databases in the
state of California with over 40,000 patients, was it just that New
York has more problems, or is it the methodology where much like
the NSQIP, these are independent nurse reviewers going back and
looking specifically at charts?
My final question, I think this lends itself to future investiga-
tion and, not being familiar with the New York statewide project,
do the investigators or the Agency for Healthcare Research and
Quality (AHRQ) have plans to perform future studies perhaps
looking at carotid angioplasty and stenting and comparing that to
the results of carotid endarterectomy in a contemporary series
within the state of New York? I thank the society for the privilege
of the floor.
Dr Alexander J. Greenstein (New York, NY). There are
several possible explanations for the relationship that we detected
betweenmajor andminor complications. First, higher rates of both
types of complications might be more common in sicker patients.
We think our CEA-specific risk adjustment model should have
accounted for most of this variation. Second, the presence of
anatomic variants or other technically difficult aspects of a case
might lead to an increase of both complications. These data are not
readily reported in the charts or easily extracted, so we were not
able to discount this as a possibility. Third, a minor complication
(eg, a large hematoma) could itself lead to death or stroke. This
wouldn’t explain the sequence for the vast majority of major
complications. Fourth, the risk of minor and major complications
might reflect the technical quality and experience of the surgeon,
operative team, and/or hospital. We think this is the most likelyexplanation, though this is difficult to prove with observational
data.
We did observe significant variations in the rates of minor and
major complications at both the individual surgeon and hospital
level. In analyses done with the surgeon (or hospital) as the unit of
analyses (not the patient as was done in this paper), surgeons (and
hospitals) with higher rates of minor complications also had higher
rates of major complications. These provider-level comparisons are
tricky because those with very low volume will have unstable point
estimates of adverse events based on chance alone. Excluding
low-volume providers solves this problem, but then limits the
generalizability of the results.
Dr Kwolek is correct that the methodology we used to
ascertain adverse events was direct clinical chart review, much
like the NSQIP. We had trained, independent research nurses
carefully review the full inpatient medical chart, including ad-
mission, discharge, daily progress, and operative notes, and
diagnostic imaging reports, and recorded information on minor
and major complications. We also did chart review on any
subsequent hospitalizations in the 30 days after surgery to
detect late strokes or deaths. Studies that rely solely on admin-
istrative billing data or just the initial hospitalization tend to
report lower rates of adverse outcomes.
Finally, the NYCAS Study reflects practice in 1998 and 1999,
so we have no data on outcomes of carotid angioplasty and
stenting.
Dr Vik Kashyap (Cleveland, Ohio). Can you explain the
methodology again to me? There were 9500 charts. How much
of the information was precoded or collected prospectively at
the time of the operations versus how many variables did you
have to go through and cull through these close to 10,000
charts to get?
DrGreenstein. As we indicate in the article, all the data in the
NYCAS Study were based on information documented in the
hospital chart as part of usual care. Our trained research nurses
retrospectively abstracted all clinical data from these hospital charts
several years after the actual care occurred. There was no prospec-
tive coding of the data for this study as might be done in a
randomized clinical trial.
Dr Kashyap. And then, in terms of the very specifics that you
have on cranial nerve policies, these were confirmed by physicians
or neurologists or were these all abstracted from the texts of the
data that was built?
Dr. Greenstein. It was a combination of the research nurse
looking at the medical chart and seeing a specific diagnosis of
cranial nerve palsy or documentation of signs or symptoms sugges-
tive of a nerve injury. If there is any question, the nurse abstractors
discussed the details with the investigative team. Cases in which a
stroke, TIA, or death was recorded by the nurses were reviewed by
two physician reviewers (including a neurologist).
Dr Kwolek. I apologize, there was one more important point
that did not come out of the presentation, but is in the manuscript,
which will be important as we start comparing this, because this
paper will be cited by the carotid angioplasty stenting advocates,
since there is a higher incidence of cranial nerve injury. One of the
subsets that needs to be broken out is temporary numbness around
the ear or earlobe or facial numbness. After an endarterectomy, I
would argue that larger number of our patients have that deficit
and whether that is coded as significant or not, needs to be
clarified.
Dr Greenstein. I have to look in to that. Thank you.
Unidentified speaker. I think my question is along the same
lines. There is a lot of difference between having a deviation of
tongue versus hoarseness of voice versus not being able to
breathe versus losing a high pitch in your voice. So, it seems to
me to be not as meaningful to have a big bucket of patients
having cranial nerve deficiency, because it really is not going to
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significance. Did you segregate and then pool it together or did
you just add it as a collective cranial nerve deficiency? Because
there are studies that say that as high as 16% incidence of
hypoglossal nerve palsy, but we do not take that as seriously as
hoarseness of voice or inability to swallow and losing the
glossopharyngeal function.
Dr Greenstein. Again, this is one of the limitations of a retro-
spective study of this nature. We have large numbers, but we do not
have the richness of clinical detail about the severity or persistence ofDr George Levinson (Bethesda, Md). Was there any cor-
relation between the use of clopidogrel preoperatively and the
incidence of early postoperative stroke due to thrombosis and
bleeding? In other words, with Plavix [Sanofi-Aventis, Bridge-
water, NJ], was there more bleeding and fewer strokes, and if
one did not have Plavix immediately preoperatively, were there
more strokes and fewer bleeding?
Dr Greenstein. The NYCAS database has data on the use of
antiplatelet agents and anticoagulants, but their potential impact
on risk of thrombotic or bleeding complications has not yet beencranial nerve injuries that could answer this question. analyzed.
